SciSparc Net Profit Margin 2017-2024 | SPRC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

SciSparc net profit margin from 2017 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

SciSparc net profit margin from 2017 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Chugai Pharmaceutical (CHGCY)	$67.7B
Zoetis (ZTS)	$65.3B
Daiichi Sankyo, - (DSNKY)	$46.2B
Takeda Pharmaceutical (TAK)	$45.9B
BeOne Medicines - (ONC)	$31.6B
Sandoz Group AG (SDZNY)	$25.8B
Summit Therapeutics (SMMT)	$21.3B
Merck (MKKGY)	$16.4B
Shionogi (SGIOY)	$15.2B
United Therapeutics (UTHR)	$13.6B
Neurocrine Biosciences (NBIX)	$12.4B
Orion OYJ (ORINY)	$10.8B
IPSEN (IPSEY)	$10.4B
Madrigal Pharmaceuticals (MDGL)	$7.7B
Corcept Therapeutics (CORT)	$7.6B
Grifols, S.A (GRFS)	$7.3B
Stevanato Group S.p.A (STVN)	$7.2B
Ionis Pharmaceuticals (IONS)	$6.6B
Hikma Pharmaceuticals Plc (HKMPF)	$5.9B
Ono Pharmaceutical (OPHLF)	$5.1B
Soleno Therapeutics (SLNO)	$4.4B
Hypermarcas (HYPMY)	$2.9B
NewAmsterdam Pharma (NAMS)	$2.8B
AMNEAL PHARMACEUTICALS, INC (AMRX)	$2.7B
Crinetics Pharmaceuticals (CRNX)	$2.5B
Catalyst Pharmaceuticals (CPRX)	$2.4B
Centessa Pharmaceuticals (CNTA)	$2.3B
Ocular Therapeutix (OCUL)	$2.1B
Endo (NDOI)	$1.8B
BioCryst Pharmaceuticals (BCRX)	$1.7B